Home
Clinical Trials
Evaluation and Natural Histor...

Evaluation and Natural History of Children With Cancer and AIDS

Last Updated: 2008-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

1994-11-30

Study Completion Date

2000-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Interferon Alfa in Treating Children With HIV-Related Cancer

NCT00002621

Leukemia Lymphoma Unspecified Childhood Solid Tumor, Protocol Specific

COMPLETED PHASE2

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

NCT00001686

Ewing's Sarcoma Leukemia Lymphoma +2 more

COMPLETED

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

NCT00002485

Brain and Central Nervous System Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor +8 more

COMPLETED

Registration and Informed Consent Study for the Childhood Cancer Research Network

NCT00433394

Unspecified Childhood Solid Tumor, Protocol Specific

COMPLETED NA

Radiation Therapy and the Natural History of Childhood Cancers

NCT00064883

Cancer Childhood Malignancy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This protocol will enable the Pediatric Branch to follow selected children with cancer or HIV infection who are not immediately eligible for protocol enrollment but who are likely, within the next year, to become candidates for protocol entry. It will also enable the Pediatric Branch to follow children who present with either clinical findings that constitute important educational experiences for the NCI trainees or who have unique or unusual medical problems that are likely to benefit from the research expertise of the NCI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Immunodeficiency Syndrome Cancer HIV Infections Leukemia Lymphoma

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease.

Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol.

No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.

Eligible Sex

ALL

Accepts Healthy Volunteers